Using a modified Delphi procedure to select a PRO-CTCAE-based subset for patient-reported symptomatic toxicity monitoring in rectal cancer patients

Publication date

2024-11

Authors

Geurts, Yvonne M.
Peters, Femke
Feldman, Esther
Roodhart, Jeanine M.L.ORCID 0000-0003-1398-8970ISNI 0000000395755635
Richir, Milan C.
Dekker, Jan Willem T
Beets, Geerard
Cnossen, Jeltsje S.
Bottenberg, Patricia
Intven, Martijn PwORCID 0000-0002-5068-5517ISNI 0000000393019546

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by

Abstract

Purpose: Standardized patient-reported outcomes (PRO) monitoring during and after rectal cancer treatment provides insight into treatment-related toxicities patients experience and improves health-related quality-of-life as well as overall survival. We aimed to select a subset of the PRO version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) for standardized monitoring of treatment-related symptomatic toxicities in rectal cancer. Methods: We used a mixed methods approach including a literature review, and semi-structured interviews with health care providers (HCPs) involved in rectal cancer care and rectal cancer patients. Results from literature and interviews were summarized and used in a modified Delphi procedure to select a PRO-CTCAE subset specific for rectal cancer. Results: Twenty-six PRO-CTCAE symptomatic toxicities were identified from literature. Fifteen HCPs from multiple disciplines (medical, radiation and surgical oncology), and a heterogeneous group of fifteen rectal cancer patients treated with chemotherapy and/or radiotherapy and/or surgery, participated in semi-structured interviews. Ten HCPs (67%) and nine patients (90%) participated in the first Delphi round. The final selected PRO-CTCAE core-subset contained 16 symptomatic toxicities: ‘diarrhea’, ‘fecal incontinence’, ‘constipation’,‘bloating of the abdomen’, ‘pain in the abdomen’, ‘vomiting’, ‘decreased libido’, ‘pain during vaginal sex’, ‘ability to achieve and maintain erection’, ‘fatigue’, ‘anxiety’, ‘feeling that nothing could cheer you up’, ‘urinary incontinence’, ‘painful urination’, ‘general pain’, and ‘hand-foot syndrome’. Conclusion: Based on a comprehensive mixed methods study, a PRO-CTCAE subset for standardized treatment-related symptomatic toxicity monitoring in rectal cancer was identified. Assessment of the effectiveness and compliance of symptomatic toxicity monitoring using this subset is recommended.

Keywords

Mixed methods, Patient reported outcome measures, Patient-centered care, Quality of life, Rectal neoplasms, Public Health, Environmental and Occupational Health

Citation

Geurts, Y M, Peters, F, Feldman, E, Roodhart, J, Richir, M, Dekker, J W T, Beets, G, Cnossen, J S, Bottenberg, P, Intven, M, Verheij, M, de Ligt, K M & Walraven, I 2024, 'Using a modified Delphi procedure to select a PRO-CTCAE-based subset for patient-reported symptomatic toxicity monitoring in rectal cancer patients', Quality of Life Research, vol. 33, no. 11, pp. 3013-3026. https://doi.org/10.1007/s11136-024-03767-0